This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Feb. 27, 2013

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  


Canadian ob-gyn groups: 25 is too late to start testing for cervical cancer
The Canadian Press via CTV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Society of Obstetricians and Gynecologists of Canada and two related medical organizations are taking issue with a national task force's recommendations that women wait until age 25 to start cervical cancer screening. In a newly released position paper, the SOGC, the Society of Gynecologic Oncology and the Society of Canadian Colposcopists say age 25 is too late to begin Pap testing because precancerous and cancerous lesions may have developed earlier in some women. More

The ASCT Foundation 2013 silent auction and raffle!
American Society for Cytotechnology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The ASCT Foundation will be hosting a silent auction and raffle at the ASCT Annual Conference, April 19-21, in Scottsdale, Ariz. One hundred percent of the auction proceeds will be used to benefit the ASCT Foundation!

In 2013, the Foundation will sponsor student conference registrations (resulting in a zero basic registration fee for students), underwrite a discounted educational luncheon for students and continue to the support the ASCT Quality Assessment Center, our new educational product.

Consider making an item donation to help the cause. Even if you are not attending the conference (though we hope you are!) you can make a difference by donating an auction item via mail. Ideas include gift cards, jewelry, arts and crafts, collectibles, food items and clothing. The donation deadline is March 12.

The ASCT Foundation is recognized as a non-profit 501(c)(3) organization by the IRS. Your tax-deductible silent auction item, as well as any cash donations, will ensure that the activities supported by the Foundation will continue to be available to all cytology professionals; and will allow us to develop programs that will sustain our mission in the future as our profession continues to evolve.

Click here for the donation form and more information.


Event Location Date Details

ASCT Webinar
Principles of Fixation and Staining for Cytopreparation
Your PC    

2 p.m. EST
March 19
More information

North Carolina Society of Cytology Spring 2013 Annual Meeting Durham, N.C.    

 April 5-6
More information

ASCT Annual Conference Hotel Valley Ho
Scottsdale, Ariz.

April 19-20
More information


CDC: Sex diseases cost $16 billion a year to treat
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Sexually transmitted diseases cost $16 billion each year to treat in the U.S., with 19.7 million infections diagnosed annually, the nation's health agency found. People ages 15 to 24 account for half of the annual cases, according to reports released recently by the Centers for Disease Control and Prevention. There are about 110 million total infections among U.S. men and women of all ages, the agency said, with the most common infection human papillomavirus, a virus linked to cancer. More

Combining synthetic, natural toxins could disarm cancer, drug-resistant bacteria
Rice University via The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancer researchers from Rice University suggest that a new man-made drug that's already proven effective at killing cancer and drug-resistant bacteria could best deliver its knockout blow when used in combination with drugs made from naturally occurring toxins. "One of the oldest tricks in fighting is the one-two punch — you distract your opponent with one attack and deliver a knockout blow with another," said José Onuchic of Rice's Center for Theoretical Biological Physics. "Combinatorial drug therapies employ that strategy at a cellular level." More

New breast cancer drug helps in advanced cases
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration approved a new "smart bomb" drug that can help women with one of the most hard-to-cure types of breast cancer. The new drug added several months of life to women with a type of breast cancer called HER2-positive breast cancer, whose tumors had spread despite treatment. While it wasn't a cure, it did add some healthy months of life to patients whose outlook was otherwise hopeless. More

Researchers gain insight into abnormally shaped cell nuclei of cancer patients
Northwestern University via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Northwestern University have recently developed a mathematical model that sheds light on the defect by clarifying the mechanisms that cause bulges known as "blebs" in cells' nuclear membranes. The research — a collaboration between experts at the McCormick School of Engineering and Applied Science and the Feinberg School of Medicine — could be a step toward bleb prevention, which may ultimately provide potential therapies for related diseases. More

Molecules generated that can halt metastasis of colon cancer
Science Codex    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A Basque research consortium has managed to halt the progress of colon cancer and its metastasis in the liver in an experimental model with mice. This advance, which may open a new path for the future treatment of such pathologies, has been achieved by creating molecules that interfere with the adhesion of tumor cells to other cells of the organism. In this way, the molecules halt both the growth of the tumor and the dissemination of the tumor to and its proliferation in other organs. More


Diabetes treatment: Stem cells show potential
The California Aggie    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a recently published study, researchers from the UCSD School of Medicine and scientists from the San Diego-based biotech company Viacyte Inc. investigated methods to create endocrine cells, specifically pancreatic T-cells, which are important in treating diabetes through their production of insulin. The study compared two methods of generating endocrine cells from stem cells, in vitro, and through transplantation of immature endocrine cells grown from mice. The malleable nature of the stem cell makes it possible to pursue both of these methods. More

DNA test for rare disorders becomes more routine
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new kind of testing is proving particularly helpful in diagnosing mysterious neurological illnesses in children. Scientists sequence all of a patient's genes, systematically searching for disease-causing mutations. A few years ago, this sort of test was so difficult and expensive that it was generally only available to participants in research projects like those sponsored by the National Institutes of Health. But the price has plunged in just a few years from tens of thousands of dollars to around $7,000 to $9,000 for a family. More

Anti-HIV drug effort in South Africa yields dramatic results
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research. The two studies, published recently in the journal Science, come as wealthy Western nations are debating how best to stretch limited AIDS funding at a time of economic stress. More

Mini microscopes see inside the brains of mice
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Mini microscopes embedded into the brains of genetically engineered mice are providing researchers a window onto the inner workings of the mammalian mind. The tool provides an unprecedentedly wide field of view on the mouse brain — in one mouse, for example, the team recorded the firing of more than 1,000 individual neurons — and it can record for weeks on end, allowing scientists to study how brain activity evolves over time. More

Artificial ear built by 3-D printer and living cartilage cells
Smithsonian    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cornell doctors and engineers presented a lifelike artificial ear made of living cells, built using 3-D printing technology. Their product, described in a paper published in PLOS ONE, is designed to help children born with congenital defects that leave them with underdeveloped outer ears, such as microtia. More

HIV linked to sudden loss of hearing
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Having HIV appears to increase the risk of sudden sensorineural hearing loss, at least among younger patients, researchers reported. Compared with HIV-negative controls, people living with HIV who were 35 or younger had double the risk of sudden hearing loss, according to Yung-Song Lin, M.D., of Taipei Medical University in Taiwan, and colleagues. More

'Zombie cells' created in lab outperform living counterparts
The Huffington Post UK    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Biological researchers have created dead "zombie" cells in the lab that outperform living cells. Seriously. A team at Sandia National Laboratories and the University of New Mexico have innovated a technique whereby mammalian cells are coated with silica to form a near-perfect replicas. The silica replicants can survive greater pressures and temperatures than flesh, and perform many functions better than the original cells did when alive. More


ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Feb. 13, 2013
Jan. 23, 2013
Jan. 9, 2013
Dec. 26, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063